SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C

Detalhes bibliográficos
Autor(a) principal: Almeida, Rita Tereza de
Data de Publicação: 2015
Outros Autores: Ciosak, Suely Itsuko
Tipo de documento: Artigo
Idioma: por
Título da fonte: Saúde e Pesquisa (Online)
Texto Completo: https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4268
Resumo: The Secretary for Science, Technology and Strategic Products of the Ministry of Health (Rule 20, of 25/7/2012) authorized the use of viral protease inhibitors in the treatment of Hepatitis C as a new technology of the Brazilian Health System. Its implementation requires that specialized service complies with criteria established by the Clinical Protocol and Therapeutic Directions. The adhesion of specialized services in the treatment of Hepatitis C with viral protease inhibitors should be verified. Current quantitative analysis was undertaken within the area of the Epidemiological Vigilance Group XVII in Campinas SP Brazil, between 5/1/13 and 5/12/2013. Sixty-five credence petitions for specialized services were evaluated in the state of São Paulo, Brazil, of which 10 were concentrated within the region under analysis. Documents mainly concerned with the attendance flux patients with Hepatitis C were analyzed, coupled to the interlinked support network. Eight services in the region analyzed received credence. Although two services were not adopted, the number of adhesions of specialized services revealed the interest of health managers to attend to criteria established by the Clinical Protocol. The administration of patients for Hepatitis C treatment requires proper infrastructure since therapy success represents hope in the patients´ lives.
id CESUMAR-1_fec7f79733bb96e8c478299d81f8c827
oai_identifier_str oai:ojs.pkp.sfu.ca:article/4268
network_acronym_str CESUMAR-1
network_name_str Saúde e Pesquisa (Online)
repository_id_str
spelling SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS CAdesão dos Serviços Especializados à Nova Tecnologia no Tratamento da Hepatite CHepatitis CBrazilian Health ServiceHealth VigilanceEpidemiological VigilanceHepatite CSistema Único de SaúdeVigilância em SaúdeVigilância EpidemiológicaThe Secretary for Science, Technology and Strategic Products of the Ministry of Health (Rule 20, of 25/7/2012) authorized the use of viral protease inhibitors in the treatment of Hepatitis C as a new technology of the Brazilian Health System. Its implementation requires that specialized service complies with criteria established by the Clinical Protocol and Therapeutic Directions. The adhesion of specialized services in the treatment of Hepatitis C with viral protease inhibitors should be verified. Current quantitative analysis was undertaken within the area of the Epidemiological Vigilance Group XVII in Campinas SP Brazil, between 5/1/13 and 5/12/2013. Sixty-five credence petitions for specialized services were evaluated in the state of São Paulo, Brazil, of which 10 were concentrated within the region under analysis. Documents mainly concerned with the attendance flux patients with Hepatitis C were analyzed, coupled to the interlinked support network. Eight services in the region analyzed received credence. Although two services were not adopted, the number of adhesions of specialized services revealed the interest of health managers to attend to criteria established by the Clinical Protocol. The administration of patients for Hepatitis C treatment requires proper infrastructure since therapy success represents hope in the patients´ lives.A Secretaria de Ciência, Tecnologia e Insumos Estratégicos do Ministério da Saúde instituiu, por meio da Portaria n° 20, de 25 de julho de 2012, a utilização de inibidores de protease virais no tratamento da Hepatite C como nova tecnologia do Sistema Único de Saúde. A sua implementação, no entanto, requer que serviços especializados atendam aos critérios estabelecidos pelo Protocolo Clínico e Diretrizes Terapêuticas, além de verificar a adesão dos serviços especializados ao tratamento da Hepatite C com inibidores de protease viral. Estudo com abordagem quantitativa, realizado na região de abrangência do Grupo de Vigilância Epidemiológica XVII - Campinas, Estado de São Paulo, Brasil, no período de 05/01 a 05/12/2013. No Estado de São Paulo foram avaliadas 65 solicitações de credenciamento de serviços especializados e, na região de estudo, 10. Foi analisada a documentação enviada, considerando principalmente o fluxo de atendimento do paciente com hepatite C e a rede de serviços de apoio “interligados”. Na região de estudo foram credenciados oito serviços. Ainda que dois serviços não tenham sido contemplados, o número de adesão dos serviços especializados mostrou a busca dos gestores da saúde em atender aos critérios estabelecidos pelo Protocolo Clínico. O manejo dos pacientes com indicação para este tratamento para a Hepatite C requer adequada infraestrutura, com recursos humanos capacitados, que garantam abordagem técnica adequada e segura, visto que o sucesso da terapêutica representa a esperança de vida para pacientes.Universidade Cesumar - UniCesumar2015-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado por ParesPesquisa Empíricia de Campoapplication/pdfhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/426810.17765/1983-1870.2015v8n2p233-238Saúde e Pesquisa; Vol 8 No 2 (2015): maio/ago.; 233-238Saúde e Pesquisa; v. 8 n. 2 (2015): maio/ago.; 233-2382176-9206reponame:Saúde e Pesquisa (Online)instname:Cesumar Diretoria de Pesquisainstacron:CESUMARporhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4268/2628Almeida, Rita Tereza deCiosak, Suely Itsukoinfo:eu-repo/semantics/openAccess2021-12-09T12:01:53Zoai:ojs.pkp.sfu.ca:article/4268Revistahttps://periodicos.unicesumar.edu.br/index.php/saudpesqPUBhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/oainaep@cesumar.br2176-92061983-1870opendoar:2021-12-09T12:01:53Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisafalse
dc.title.none.fl_str_mv SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
Adesão dos Serviços Especializados à Nova Tecnologia no Tratamento da Hepatite C
title SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
spellingShingle SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
Almeida, Rita Tereza de
Hepatitis C
Brazilian Health Service
Health Vigilance
Epidemiological Vigilance
Hepatite C
Sistema Único de Saúde
Vigilância em Saúde
Vigilância Epidemiológica
title_short SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
title_full SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
title_fullStr SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
title_full_unstemmed SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
title_sort SPECIALIZED SERVICES IN NEW TECHNOLOGIES FOR THE TREATMENT OF HEPATITIS C
author Almeida, Rita Tereza de
author_facet Almeida, Rita Tereza de
Ciosak, Suely Itsuko
author_role author
author2 Ciosak, Suely Itsuko
author2_role author
dc.contributor.author.fl_str_mv Almeida, Rita Tereza de
Ciosak, Suely Itsuko
dc.subject.por.fl_str_mv Hepatitis C
Brazilian Health Service
Health Vigilance
Epidemiological Vigilance
Hepatite C
Sistema Único de Saúde
Vigilância em Saúde
Vigilância Epidemiológica
topic Hepatitis C
Brazilian Health Service
Health Vigilance
Epidemiological Vigilance
Hepatite C
Sistema Único de Saúde
Vigilância em Saúde
Vigilância Epidemiológica
description The Secretary for Science, Technology and Strategic Products of the Ministry of Health (Rule 20, of 25/7/2012) authorized the use of viral protease inhibitors in the treatment of Hepatitis C as a new technology of the Brazilian Health System. Its implementation requires that specialized service complies with criteria established by the Clinical Protocol and Therapeutic Directions. The adhesion of specialized services in the treatment of Hepatitis C with viral protease inhibitors should be verified. Current quantitative analysis was undertaken within the area of the Epidemiological Vigilance Group XVII in Campinas SP Brazil, between 5/1/13 and 5/12/2013. Sixty-five credence petitions for specialized services were evaluated in the state of São Paulo, Brazil, of which 10 were concentrated within the region under analysis. Documents mainly concerned with the attendance flux patients with Hepatitis C were analyzed, coupled to the interlinked support network. Eight services in the region analyzed received credence. Although two services were not adopted, the number of adhesions of specialized services revealed the interest of health managers to attend to criteria established by the Clinical Protocol. The administration of patients for Hepatitis C treatment requires proper infrastructure since therapy success represents hope in the patients´ lives.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Avaliado por Pares
Pesquisa Empíricia de Campo
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4268
10.17765/1983-1870.2015v8n2p233-238
url https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4268
identifier_str_mv 10.17765/1983-1870.2015v8n2p233-238
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4268/2628
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Cesumar - UniCesumar
publisher.none.fl_str_mv Universidade Cesumar - UniCesumar
dc.source.none.fl_str_mv Saúde e Pesquisa; Vol 8 No 2 (2015): maio/ago.; 233-238
Saúde e Pesquisa; v. 8 n. 2 (2015): maio/ago.; 233-238
2176-9206
reponame:Saúde e Pesquisa (Online)
instname:Cesumar Diretoria de Pesquisa
instacron:CESUMAR
instname_str Cesumar Diretoria de Pesquisa
instacron_str CESUMAR
institution CESUMAR
reponame_str Saúde e Pesquisa (Online)
collection Saúde e Pesquisa (Online)
repository.name.fl_str_mv Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisa
repository.mail.fl_str_mv naep@cesumar.br
_version_ 1754122533519491072

Registros relacionados